Cencora Gross Margin 2010-2023 | COR
Current and historical gross margin for Cencora (COR) over the last 10 years. The current gross profit margin for Cencora as of December 31, 2023 is %.
| Cencora Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2023-12-31 | $271.58B | $9.28B | 3.42% |
| 2023-09-30 | $262.17B | $8.96B | 3.42% |
| 2023-06-30 | $254.43B | $8.69B | 3.42% |
| 2023-03-31 | $247.54B | $8.44B | 3.41% |
| 2022-12-31 | $241.81B | $8.38B | 3.47% |
| 2022-09-30 | $238.59B | $8.30B | 3.48% |
| 2022-06-30 | $236.33B | $8.38B | 3.55% |
| 2022-03-31 | $229.67B | $8.25B | 3.59% |
| 2021-12-31 | $221.10B | $7.55B | 3.41% |
| 2021-09-30 | $213.99B | $6.94B | 3.24% |
| 2021-06-30 | $204.32B | $6.22B | 3.04% |
| 2021-03-31 | $196.28B | $5.56B | 2.83% |
| 2020-12-31 | $194.55B | $5.41B | 2.78% |
| 2020-09-30 | $189.90B | $5.19B | 2.73% |
| 2020-06-30 | $186.29B | $5.03B | 2.70% |
| 2020-03-31 | $186.16B | $5.04B | 2.70% |
| 2019-12-31 | $182.06B | $5.07B | 2.79% |
| 2019-09-30 | $179.59B | $5.14B | 2.86% |
| 2019-06-30 | $177.25B | $4.99B | 2.81% |
| 2019-03-31 | $175.15B | $4.97B | 2.84% |
| 2018-12-31 | $172.87B | $4.80B | 2.78% |
| 2018-09-30 | $167.94B | $4.61B | 2.75% |
| 2018-06-30 | $163.76B | $4.75B | 2.90% |
| 2018-03-31 | $159.33B | $4.62B | 2.90% |
| 2017-12-31 | $155.44B | $4.62B | 2.97% |
| 2017-09-30 | $153.14B | $4.55B | 2.97% |
| 2017-06-30 | $151.58B | $4.50B | 2.97% |
| 2017-03-31 | $149.76B | $4.53B | 3.02% |
| 2016-12-31 | $148.31B | $4.35B | 2.93% |
| 2016-09-30 | $146.85B | $4.27B | 2.91% |
| 2016-06-30 | $144.76B | $4.12B | 2.85% |
| 2016-03-31 | $142.11B | $3.91B | 2.75% |
| 2015-12-31 | $139.08B | $3.74B | 2.69% |
| 2015-09-30 | $135.96B | $3.53B | 2.60% |
| 2015-06-30 | $132.08B | $3.43B | 2.60% |
| 2015-03-31 | $128.20B | $3.23B | 2.52% |
| 2014-12-31 | $123.98B | $3.05B | 2.46% |
| 2014-09-30 | $119.57B | $2.98B | 2.49% |
| 2014-06-30 | $112.45B | $2.68B | 2.38% |
| 2014-03-31 | $104.01B | $2.55B | 2.45% |
| 2013-12-31 | $96.08B | $2.54B | 2.64% |
| 2013-09-30 | $87.96B | $2.51B | 2.85% |
| 2013-06-30 | $82.23B | $2.64B | 3.21% |
| 2013-03-31 | $79.65B | $2.75B | 3.45% |
| 2012-12-31 | $78.83B | $2.71B | 3.44% |
| 2012-09-30 | $78.08B | $2.64B | 3.37% |
| 2012-06-30 | $78.23B | $2.47B | 3.16% |
| 2012-03-31 | $79.07B | $2.46B | 3.11% |
| 2011-12-31 | $79.12B | $2.46B | 3.11% |
| 2011-09-30 | $78.70B | $2.46B | 3.12% |
| 2011-06-30 | $79.35B | $2.48B | 3.13% |
| 2011-03-31 | $78.79B | $2.42B | 3.07% |
| 2010-12-31 | $78.33B | $2.34B | 2.99% |
| 2010-09-30 | $77.78B | $2.32B | 2.99% |
| 2010-06-30 | $76.96B | $2.30B | 2.99% |
| 2010-03-31 | $75.75B | $2.23B | 2.95% |
| 2009-12-31 | $73.76B | $2.17B | 2.95% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $48.051B | $262.173B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $124.869B | 15.67 |
| ICON (ICLR) | Ireland | $25.434B | 24.01 |
| DiDi Global (DIDIY) | China | $24.387B | 0.00 |
| Avantor (AVTR) | United States | $16.238B | 23.94 |
| Viatris (VTRS) | United States | $13.880B | 3.96 |
| CochLear (CHEOY) | $13.776B | 0.00 | |
| Revvity (RVTY) | United States | $12.539B | 21.83 |
| Medpace Holdings (MEDP) | United States | $12.267B | 40.36 |
| Charles River Laboratories (CRL) | United States | $11.798B | 21.51 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.548B | 0.00 |
| Natera (NTRA) | United States | $11.205B | 0.00 |
| Solventum (SOLV) | United States | $11.115B | 0.00 |
| HealthEquity (HQY) | United States | $6.886B | 51.45 |
| Bausch + Lomb (BLCO) | Canada | $5.197B | 19.99 |
| Organon (OGN) | United States | $4.742B | 4.59 |
| Doximity (DOCS) | United States | $4.444B | 33.08 |
| PACS (PACS) | United States | $3.713B | 0.00 |
| Sotera Health (SHC) | United States | $3.227B | 15.83 |
| Surgery Partners (SGRY) | United States | $3.108B | 28.88 |
| Progyny (PGNY) | United States | $3.079B | 51.68 |
| GoodRx Holdings (GDRX) | United States | $2.840B | 143.80 |
| Life Times (LTH) | United States | $2.783B | 30.76 |
| Premier (PINC) | United States | $2.511B | 9.19 |
| Teladoc Health (TDOC) | United States | $2.203B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.164B | 7.00 |
| Agilon Health (AGL) | United States | $2.055B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.811B | 0.00 |
| Agiliti (AGTI) | United States | $1.368B | 22.33 |
| NovoCure (NVCR) | Jersey | $1.360B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.331B | 0.00 | |
| Alignment Healthcare (ALHC) | United States | $0.985B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.760B | 7.86 |
| Embecta (EMBC) | United States | $0.594B | 3.92 |
| InnovAge Holding (INNV) | United States | $0.531B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.522B | 0.00 |
| Enhabit (EHAB) | United States | $0.503B | 45.59 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.492B | 0.00 |
| LifeMD (LFMD) | United States | $0.482B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.434B | 0.00 |
| Beauty Health (SKIN) | United States | $0.400B | 0.00 |
| CareDx (CDNA) | United States | $0.391B | 0.00 |
| DocGo (DCGO) | United States | $0.376B | 60.17 |
| MultiPlan (MPLN) | United States | $0.371B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.349B | 0.00 |
| ModivCare (MODV) | United States | $0.335B | 4.44 |
| Sharecare (SHCR) | United States | $0.290B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.289B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.269B | 0.00 |
| Biodesix (BDSX) | United States | $0.142B | 0.00 |
| So-Young (SY) | China | $0.125B | 41.83 |
| Oncology Institute (TOI) | United States | $0.085B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.078B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.055B | 0.00 |
| NeueHealth (NEUE) | United States | $0.050B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.035B | 0.00 |
| Nutex Health (NUTX) | United States | $0.033B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.024B | 0.00 |
| DermTech (DMTK) | United States | $0.021B | 0.00 |
| OncoCyte (OCX) | United States | $0.021B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.014B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.007B | 0.00 |
| Assure Holdings (IONM) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |